Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form
Authors:
- Gisella FiglioliGFGisella Figlioli
- Stefano LandiSLStefano Landi
- Cristina RomeiCRCristina Romei
- Rossella EliseiRERossella Elisei
- Federica GemignaniFGFederica Gemignani
- 1 January 2013
- journal article
- research article
- Published by Elsevier in Mutation Research - Reviews in Mutation Research
- Vol. 752 (1) , 36-44
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Medullary thyroid carcinoma with nodular goiter carries an excellent prognosisJournal of Surgical Oncology, 2012
- Medullary thyroid carcinomaClinical Endocrinology, 2004
- Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survivalEuropean Journal of Surgical Oncology, 2000
- Medullary thyroid carcinomaCancer, 2000
- Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patientsClinical Endocrinology, 1998
- Long term follow-up of patients with medullary carcinoma of the thyroidCancer, 1997
- Medullary Thyroid Cancer: Analyses of Survival and Prognostic Factors and the Role of Radiation Therapy in Local ControlThyroid®, 1996
- Multivariate analysis of patients with medullary thyroid carcinoma: Prognostic significance and impact on treatment of clinical and pathologic variablesCancer, 1996
- Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma RegisterJournal of Molecular Medicine, 1993
- Medullary Thyroid Carcinoma: Clinicopathologic Features and Long-Term Follow-Up of 65 Patients Treated During 1946 Through 1970Mayo Clinic Proceedings, 1992